# Horton D R Inc: overview

DHI · NYSE · CIK 882184 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/dhi.md) · [Financials](/companies/dhi/financials.md) · [Filings](/companies/dhi/filings.md) · [Insiders](/companies/dhi/insiders.md)

Latest reported revenue: [$9.23bn](/filings/0000882184-26-000096.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 23, 2026 (XBRL us-gaap:Revenues, accession 0000882184-26-000096).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.0 d](/filings/0000882184-25-000081.md) | [7.6](/filings/0000882184-26-000014.md) | [7.7](/filings/0000882184-26-000081.md) | [9.2](/filings/0000882184-26-000096.md) | [9.7 d](/filings/0000882184-25-000081.md) | [6.9](/filings/0000882184-26-000014.md) | [7.6](/filings/0000882184-26-000081.md) | [9.2](/filings/0000882184-26-000096.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [12.8% d](/filings/0000882184-25-000081.md) | [11.1%](/filings/0000882184-26-000014.md) | [10.5%](/filings/0000882184-26-000081.md) | [11.1%](/filings/0000882184-26-000096.md) | [9.4% d](/filings/0000882184-25-000081.md) | [8.6%](/filings/0000882184-26-000014.md) | [8.6%](/filings/0000882184-26-000081.md) | [9.8%](/filings/0000882184-26-000096.md) |
| Diluted EPS | $ per share | not reported | [2.61](/filings/0000882184-26-000014.md) | [2.58](/filings/0000882184-26-000081.md) | [3.36](/filings/0000882184-26-000096.md) | not reported | [2.03](/filings/0000882184-26-000014.md) | [2.24](/filings/0000882184-26-000081.md) | [3.20](/filings/0000882184-26-000096.md) |
| Free cash flow | $bn | [1.9 d](/filings/0000882184-25-000081.md) | [0.6](/filings/0000882184-26-000014.md) | [(0.5) d](/filings/0000882184-26-000081.md) | [0.7 d](/filings/0000882184-26-000096.md) | [2.4 d](/filings/0000882184-25-000081.md) | [0.8](/filings/0000882184-26-000014.md) | [(0.4) d](/filings/0000882184-26-000081.md) | [0.4 d](/filings/0000882184-26-000096.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [27.8](/filings/0000882184-23-000115.md) | [33.5](/filings/0000882184-24-000057.md) | [35.5](/filings/0000882184-25-000081.md) | [36.8](/filings/0000882184-25-000081.md) | [34.3](/filings/0000882184-25-000081.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [15.0%](/filings/0000882184-23-000115.md) | [17.5%](/filings/0000882184-24-000057.md) | [13.4%](/filings/0000882184-25-000081.md) | [12.9%](/filings/0000882184-25-000081.md) | [10.5%](/filings/0000882184-25-000081.md) |
| Diluted EPS | $ per share | [11.41](/filings/0000882184-23-000115.md) | [16.51](/filings/0000882184-24-000057.md) | [13.82](/filings/0000882184-25-000081.md) | [14.34](/filings/0000882184-25-000081.md) | [11.57](/filings/0000882184-25-000081.md) |
| Free cash flow | $bn | [0.4](/filings/0000882184-23-000115.md) | [0.4](/filings/0000882184-24-000057.md) | [4.2](/filings/0000882184-25-000081.md) | [2.0](/filings/0000882184-25-000081.md) | [3.3](/filings/0000882184-25-000081.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dhi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $6.07bn | 37,280,759 |  | Added +344,653 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.07bn | 24,974,471 |  | Reduced −2,868,761 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.76bn | 16,937,322 |  | Reduced −283,907 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.02bn | 12,400,299 |  | Reduced −166,203 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.97bn | 12,077,744 |  | Added +218,147 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.54bn | 9,440,491 |  | Reduced −323,107 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.17bn | 7,224,096 |  | Reduced −50,778 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $926.3m | 5,686,635 |  | Added +1,028,889 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $602.0m | 3,696,034 |  | Reduced −147,834 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $579.0m | 3,554,668 |  | Added +28,705 |

## Recent filings

[All 1,401 filings](/companies/dhi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 12:51 ET | [8-K](/filings/0000882184-26-000119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000882184-26-000119 |
| 2026-10-26 | 16:35 ET | [8-K](/filings/0000882184-26-000113.md) | 5.02 Departure or appointment of officers or directors | 0000882184-26-000113 |
| 2026-09-15 | 17:09 ET | [8-K](/filings/0000882184-26-000108.md) | 8.01 Other events | 0000882184-26-000108 |
| 2026-07-23 | 16:10 ET | [10-Q](/filings/0000882184-26-000096.md) | Quarterly report, period 2026-06-30 | 0000882184-26-000096 |
| 2026-07-21 | 11:54 ET | [8-K](/filings/0000882184-26-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000882184-26-000092 |
| 2026-05-12 | 09:45 ET | [8-K](/filings/0000882184-26-000087.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000882184-26-000087 |
| 2026-04-23 | 14:31 ET | [10-Q](/filings/0000882184-26-000081.md) | Quarterly report, period 2026-03-31 | 0000882184-26-000081 |
| 2026-04-21 | 12:11 ET | [8-K](/filings/0000882184-26-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000882184-26-000062 |
| 2026-03-31 | 17:15 ET | [8-K](/filings/0000882184-26-000053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000882184-26-000053 |
| 2026-01-22 | 15:00 ET | [10-Q](/filings/0000882184-26-000014.md) | Quarterly report, period 2025-12-31 | 0000882184-26-000014 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0000882184-25-000081.md), filed Nov 19, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/079a5f6f-fadc-4b3f-a1c1-b0abe001a687)

## About the filer

- CIK: 882184
- Tickers: DHI
- Exchange: NYSE
- SIC code: 1531 Operative Builders
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 12:52 ET. No prices; not investment advice.